Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT04459559Not ApplicableUnknown

Usability of a Novel Cueing Device for Patients With Parkinson's Disease

Role: collaborator

NCT03641651Not ApplicableCompleted

New Technologies in the Rehabilitation of Chronic Stroke

Role: collaborator

NCT05485597Not ApplicableUnknown

Myosuit-based Gait Training

Role: lead

NCT03100422Not ApplicableCompleted

Strategies of Therapy With the Exoskeleton Robot ARMin

Role: collaborator

NCT03720106Not ApplicableUnknown

The Way to Goal-oriented Therapy Planning in Neurorehabilitation

Role: lead

NCT02735460Not ApplicableCompleted

Usability of Andago V2.0 in Gait Rehabilitation of Stroke Patients

Role: lead

All 6 trials loaded